Form 4 for NEO NEOGENOMICS INC
Accepted 2022-06-14 00:00:00 ET · period of report 2022-06-10 · accession 0001077183-22-000109 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-14 | 2022-06-10 | NEO | Stahler Rachel A | Dir | A - Grant | $0.00 | +15.6K | 21.3K | +269% | $0 |
| D | 2022-06-14 | 2022-06-10 | NEO | Stahler Rachel A | Dir | A - Grant | $0.00 | +13.9K | 13.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-10 | A | A | 15,556 | $0.00 | 21,335 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-06-10 | A | A | 13,882 | $0.00 | 13,882 | D | $8.10 · 2023-06-10 to 2029-06-10 | 13,882 Common Stock |